From: Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk
Genotype | Cases | Controls | Crude modela | Adjusted modelb | Â | ||||
---|---|---|---|---|---|---|---|---|---|
 | n | % | n | % | OR (95% CI) |  | OR (95% CI) |  | P c |
TaqI | 1,403 | Â | 2,609 | Â | Â | Â | Â | Â | 0.33 |
   TT | 497 | 35.4 | 980 | 37.6 | 1 |  | 1 |  |  |
   Tt | 667 | 47.6 | 1,218 | 46.7 | 1.08 | (0.94–1.25) | 1.08 | (0.93–1.26) |  |
   tt | 239 | 17.0 | 411 | 15.7 | 1.15 | (0.95–1.39) | 1.11 | (0.91–1.36) |  |
   Tt/tt |  |  |  |  | 1.10 | (0.96–1.26) | 1.09 | (0.95–1.26) |  |
FokI | 1,390 | Â | 2,596 | Â | Â | Â | Â | Â | 0.24 |
   FF | 566 | 40.7 | 998 | 38.5 | 1 |  | 1 |  |  |
   Ff | 606 | 43.6 | 1,203 | 46.3 | 0.88 | (0.77–1.02) | 0.89 | (0.77–1.03) |  |
   ff | 218 | 15.7 | 395 | 15.2 | 0.98 | (0.80–1.19) | 0.97 | (0.79–1.19) |  |
   Ff/ff |  |  |  |  | 0.91 | (0.80–1.04) | 0.91 | (0.79–1.05) |  |
VDR-5132 | 1,400 | Â | 2,607 | Â | Â | Â | Â | Â | 0.92 |
   CC | 488 | 34.9 | 892 | 34.2 | 1 |  | 1 |  |  |
   CT | 683 | 48.8 | 1,284 | 49.3 | 0.99 | (0.85–1.14) | 1.00 | (0.86–1.16) |  |
   TT | 229 | 16.3 | 431 | 16.5 | 0.99 | (0.81–1.20) | 1.01 | (0.83–1.24) |  |
   CT/TT |  |  |  |  | 0.99 | (0.86–1.13) | 1.00 | (0.87–1.16) |  |
Cdx2 | 1,406 | Â | 2,606 | Â | Â | Â | Â | Â | 0.22 |
   GG | 888 | 63.1 | 1,701 | 65.3 | 1 |  | 1 |  |  |
   GA | 465 | 33.1 | 795 | 30.5 | 1.11 | (0.97–1.28) | 1.08 | (0.94–1.25) |  |
   AA | 53 | 3.8 | 110 | 4.2 | 0.94 | (0.67–1.32) | 0.94 | (0.66–1.33) |  |
   GA/AA |  |  |  |  | 1.09 | (0.95–1.25) | 1.07 | (0.93–1.23) |  |